多发性硬化症:发病机制和生物标志物
Ashwani Arya1, Manish Dhall2, Vineet Mittal3
1Department of Pharmaceutical Education and Research, South Campus, Bhainswal Kalan, Bhagat Phool Singh Mahila Vishwavidyalaya, Khanpur Kalan, Sonepat, Haryana, India.
Central nervous system agents in medicinal chemistry
|September 5, 2024
概括
多发性硬化症 (MS) 是一种中枢神经系统 (CNS) 神经退行性疾病. 本综述强调了MS的关键生物标志物,为有效治疗提供了潜在的治疗目标.
科学领域:
- 神经学 神经学
- 神经免疫学 神经免疫学
- 神经退行发生神经退行.
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统 (CNS) 的慢性,炎症性和神经退行性疾病.
- 它的特点是神经症状波动和渐进的残疾.
- 多发性硬化症的确切病因尚未确定,因此需要对其病理生理学的进一步研究.
研究的目的:
- 提供MS疾病活动,进展和发病机制的简要概述.
- 强调生物标志物在MS中的作用,作为潜在的治疗点.
- 为了确定MS的新型治疗干预措施.
主要方法:
- 使用主要的科学网站和搜索引擎进行了全面的文献调查.
- 分析了有关多发性硬化病原和生物标志物的关键研究论文和评论.
- 合成了有关病理特征和治疗价值的生物标志物的信息.
主要成果:
- 多发性硬化症的病理特征包括皮质炎症,神经退行,脱髓化,轴突损伤/损失和质激活.
- 已经确定了许多生物标志物,如中枢神经系统神经丝,GFAP,CXCL13和miRNA.
- 这些生物标志物对于了解疾病机制和开发向疗法至关重要.
结论:
- 了解MS病理生理学和识别特定的生物标志物对于治疗干预至关重要.
- 生物标志物可以帮助识别有风险的个体,并提高进展性多发性硬化症的治疗疗效.
- 对多发性硬化症生物标志物的进一步研究有望促进治疗策略和患者的治疗结果.
相关概念视频
01:15Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
520
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
520